Ignite Creation Date:
2024-05-06 @ 3:13 PM
Last Modification Date:
2024-10-26 @ 1:45 PM
Study NCT ID:
NCT04557956
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2020-09-18
Brief Title:
Testing the Addition of the Anti-cancer Drug Tazemetostat to the Usual Treatment Dabrafenib and Trametinib for Metastatic Melanoma That Has Progressed on the Usual Treatment
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Metastatic Melanoma |
| Clinical Stage IV Cutaneous Melanoma AJCC v8 |
Keywords: